Outstanding (10-Q cover 2026-08-14) less insider holdings (8 shares total per DEF 14A).
Data-service feed, fetched today. The number TradingView and most screeners show.
Your screener's float is right for XXII. Trade off 599.5K shares. What it does not show you is what is about to be added to it.
The float your screener shows is right, at 599.5K. An active $6.4M ATM, 1 floorless convertible note and 7 reverse splits can add another 522% of the float.
Abeyance share overhang — registered, paid-for, unissued supply. On 2026-08-13 the company cut the exercise price on all 3,019,586 June 2026 Inducement Warrants to $0.3675 (against a $4.11 close) and permitted cashless exercise.
Serial reverse splits / prior dilution cycle. Six reverse splits in 37 months: 1-for-15 (2023-07-05), 1-for-16 (2024-04-02), 1-for-135 (2024-12-17), 1-for-23 (2025-06-20), 1-for-15 (2026-01-26), 1-for-20 (2026-06-12) — cumulative compression of…
Authorized but unissued floating-rate financings. Stockholders approved on 2026-08-05 two future offerings against a $2.23mm market cap: (a) up to $20mm of new convertible preferred with warrants — conversion at the Nasdaq Minimum Price with a floor…
From today's float to the ceiling
sharesWhere the shares come from
each subtotal is a rung on the ladder above
ATM program active with $6.4M of registered capacity remaining. Public float is under $75M, so the baby-shelf rule caps primary sales near $125K per 12 months; the headline figure is not the near-term supply.
Not counted anywhere: ATM and shelf capacity. Convertible share counts use stated conversion prices.
See the full breakdown
Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.
Sign in to continueThe facts
Market data as of Oct 16, 2026
Key dates
- Mar 20, 2027 · Deadline for investors to request the remaining ~$3.975mm Series B second closing; Company may compel it sooner once <50% of an investor's initial Series B rem…